Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects. - Deacon,CF.; Nauck,MA.; Toft-Nielsen,M.; Pridal,L.; Willms,B.; Holst,JJ. (Diabetes, 1995)